February 24 2020

LINCOMYCIN

List of brands containing lincomycin   

This page contains a list of brands of authorized pharmaceutical specialties of the active principle lincomycin in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed their name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Indications and usage     

Lincomycin is an antibiotic with activity against gram-positive aerobic bacteria such as streptococci, pneumococci, and staphylococci. This drug diffuses into organic liquids properly and also into most tissues, being effective for the treatment of infections caused by germs sensitive to this substance, both aerobic and anaerobic.

These infections include:

- Upper respiratory tract infections such as tonsillitis, pharyngitis, sinusitis, average otitis media, scarlet fever and as a supportive treatment for diphtheria.
- Lower airways tract infections, such as acute and chronic bronchitis, pneumonia.
- Skin and soft tissue infections (boils, cellulitis, impetigo, abscesses, acne, and wound infections, erysipelas, lymphadenitis, paronychia, mastitis and cutaneous gangrene
- Bones and joints infections (osteomyelitis and septic arthritis)
- Septicemia and endocarditis
- Bacillary dysentery. Although Shigella is frequently resistant to lincomycin in susceptibility testing, the drug has been effective in vivo due to the very high levels reached in the intestinal contents.

The lincomycin parenterally (intramuscular or intravenous) is an antibiotic indicated for the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci.

Its use should be reserved for patients allergic to penicillin and other patients that, in the doctor's opinion, the use of penicillin is inappropriate.

Because of the risk of pseudomembranous colitis associated with the use of antibiotics, the doctor will assess the possibility of using other drugs with lower risk.

LINCOMYCIN IS NOT INDICATED IN THE TREATMENT OF MILD INFECTIONS OR CAUSED BY VIRUSES.

Medizzine recommends consulting your doctor if you are unsure (or you do not know) why you have been given lincomycin.

Other ingredients of available commercial presentations:

Capsules:

Each capsule contains, in addition to 500 mg of active ingredient, talc, lactose and magnesium stearate

Ampules/vials

Each ml of solution contains 300 mg lincomycin and 9.45 mg benzyl alcohol. The other is water for injection.

Warning:

The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.

Important information     

Lincomycin capsules contain lactose. If your doctor has told you that you have an intolerance to certain sugars, consult him before taking this medicine.

This medicine in injectable solution contains benzyl alcohol, so should not be used for premature infants and babies under a month of life.

Before taking the drug     

Do not use lincomycin

If you are allergic (hypersensitive) to lincomycin, to clindamycin or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.

Allergy symptoms may include:

- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).

Nor you should take this medicine:

- Infants under one-month-old
- This medicine should not be administered to patients with preexisting monilial infections.

If this situation is applicable to you or you are not sure, tell your doctor before taking this medicine.

Take special care with lincomycin

- If you have a neuromuscular disorder or you are receiving a neuromuscular blocking. It has been shown that lincomycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents, which should be used with caution in patients receiving such drugs.
- If you have a history of colitis
- If you have a liver disease
- If you have a kidney disease
- If you have an endocrine or metabolic disease

NOT recommended, usually use this antibiotic in case of important disease of these organs (liver, kidney). The doctor may make a functional assessment of them before or during treatment, especially if this should be prolonged.

Lincomycin interferes with the following laboratory tests:

- Transaminases (ALT/ SGPT, AST/SGOT)
- Alkaline Phosphatase

The analytical values of these liver enzymes may be elevated.

Remember that your doctor has prescribed this medicine only for you. Never give it to someone else.

If in doubt, consult your doctor.

Taking other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal products or drugs obtained without a prescription.

Lincomycin presents interaction with the following medicines:

- Chloroform
- Cyclopropane
- enflurane
- Halothane
- Isoflurane
- Methoxyflurane
- Trichloroethylene
- Neuromuscular Blockers
- Kanamycin and novobiocin (parenteral).
- Erythromycin
- Antidiarrheals reducing intestinal motility and absorbents, antiperistaltic opiates, difenoxin, diphenoxylate, loperamide, kaolin and attapulgite
- Medicines to treat neuromuscular diseases Chloramphenicol and narcotic analgesics.

Absorbents antidiarrheal reduce the absorption of lincomycin orally, so it should be administered two hours before or 4 hours after antibiotic administration.

Use with food and beverages

To achieve adequate absorption of the drug should be avoided taking food or drink from two hours before until two hours after taking the drug.

The absorption of orally administered lincomycin is reduced when administered in the presence of cyclamates contained in food or drink.

Taken together lincomycin and alcoholic beverages increases the risk of side effects from medicine.

Special physiological situations

Pregnancy and lactation:

Always consult your doctor or pharmacist before taking any medicine during pregnancy or breastfeeding.

Lincomycin crosses the placenta and reaches a concentration of 25% of the level of the mother in the umbilical cord. However, there are no controlled and appropriate studies in pregnant women, so it can not guarantee the safety of the drug to the fetus. A study of 322 women who received lincomycin orally at doses of 500 mg four times daily for seven days while pregnant, revealed no detrimental effect on the mother or fetus.

Studies in laboratory animals at doses above 50 times higher than used in humans have not recorded any damage either fetal or embryonic.

This antibiotic should be used during pregnancy only if the doctor considers that the benefit of its utilization exceeds the potential risk to the fetus.

lactation:

Lincomycin is eliminated through breast milk, where it can reach a concentration of 0.5-2.4 mcg/ml. Because of the risk for serious adverse reactions in the baby, lincomycin is considered incompatible with breastfeeding, so it is necessary to decide whether the drug is replaced by another or breastfeeding is suspended.

Children:

The use of lincomycin in children under 1 month of age can lead to the so-called gasping syndrome, which can be fatal, related to benzyl alcohol excipient.

Eñderñy

There are no limitations depending on the patient's age, but according to his good liver or kidneys function.

Driving and using machines

It is unlikely that the drug affects your concentration and alertness.

Consult your doctor or pharmacist before taking any medicine.

How to use lincomycin     

Follow carefully the instructions of use of lincomycin provided by your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given on this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.

If diarrhea occurs during treatment, discontinue treatment with lincomycin and promptly consult your doctor. As with other antibiotics, treatment with lincomycin has been associated with episodes of severe colitis, which can endanger the patient's life. These are episodes of colitis caused by Clostridium Difficile and its enterotoxin. If the disease progresses, it can lead to intestinal perforation, peritonitis, and shock. It usually occurs during treatment, but sometimes it appears up to 15-20 days after taking the drug.

Intramuscular use

Adults:

ISerious infection: 600 mg (2 mL) every 12-24 hours, depending on the severity of the case

Children older than one month:

Serious infections: 10 mg/kg every 12-24 hours, depending on the severity of the case.

Intravenous use

Adults and children:

The dose and interval between them will be determined by the doctor, depending on the severity of the infection being treated. Overall, lincomycin for this route it is used as a diluted infusion because serious cardiopulmonary reactions may occur if administered at higher concentrations than recommended.

Subconjunctival use:

For the treatment of eye infections, this route is used at a dose of 75 mg/ each, which provides a drug concentration suitable for most of the susceptible germs.

Oral use:

Adults: One 500 mg capsule 3 or 4 times a day, depending on the severity of the case.

Children older than one month: 30-60 mg/kg/day (total daily dose) divided into 3 or 4 doses, depending on the severity of the case

Patients with impaired renal function:

When the patient has decreased kidney function, is advisable administer proportionately lower doses of this medication.

If you think the effect of the medicine is too strong or too weak, consult your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

While you take lincomycin     

If a doctor prescribes another medicine, tell you are taking lincomycin.

Check with your doctor regularly developments of disorder that motivates the use of lincomycin. Maybe there is some reason that prevented you properly receive the indicated doses and induce your doctor to erroneous conclusions about treatment.

Do not restart treatment with lincomycin at your own risk without first talking to your doctor, nor encourage its use by another person, even if have the same symptoms you have. Nor is it advisable to interrupt or reduce the dose without considering the opinion of your doctor.

If you feel unwell during treatment with lincomycin, immediately consult your doctor.

If you take more than you should:

Consult your doctor or pharmacist or call a Poison Control Center in your country, indicating the medicine and ingested dose.

In the case of accidental ingestion, go to the emergency room of the nearest hospital. Take the pack and the rest of unconsumed medicine.

If you forget to take lincomycin

Take your dose as soon as you remember and continue with the doses and the interval between them set by your doctor.

Do not take a double dose to make up for forgotten individual doses.

If you stop taking lincomycin

You should not stop treatment without the knowledge and approval of your doctor as it may worsen your infectious process.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Side Effects of lincomycin     

Like all medicines, lincomycin can cause side effects although not everybody gets them.

The frequency of side effects is classified into:

Very common: affect 1 out of 1-10 patients
Common: affect 1 out of 10-100 patients
Uncommon: affect 1 out of 100-1.000 patients
Rare: affect 1 out of 1.000-10.000 patients
Very Rare: affect less than 1 in 10,000 patients
Incidence not known: Can not be established the true incidence from the available data

Gastrointestinal side effects

Glossitis, stomatitis, nausea, vomiting diarrhea and/or colitis and anal itching. The start of the pseudomembranous colitis can occur during or after treatment. The oral intake can lead to esophagitis.

Side effects on blood

Neutropenia, leukopenia, and agranulocytosis. There have been reports of thrombocytopenic purpura, and aplastic anemia or pancytopenia, in which there has not been ruled out lincomycin as the causal agent.

Hypersensitivity reactions

angioneurotic edema, serum sickness-like syndrome and episodes of anaphylaxis. Rare cases of erythema multiforme and Stevens-Johnson syndrome. If any case of allergic reactions or urticaria indicated type, eczema or rhinitis, treatment should be discontinued immediately and consult your doctor.

Adverse effects on the skin and mucous membranes

Rashes, urticaria, and vaginitis. Rare cases of vesiculobullous or exfoliative dermatitis.

Adverse effects on the liver:

No link has been established between possible functional disorders of the liver and lincomycin; have been observed changes in transaminases and jaundice.

Adverse effects on the kidney:

There have been rare cases of elevation of urea, oliguria, and proteinuria. Not established a causal relationship to the use of lincomycin.

Cardiovascular side effects:

The excessively rapid intravenous administration or slightly diluted lincomycin may induce a cardiorespiratory arrest and hypotension.

Adverse effects on sensorial organs:

Tinnitus and vertigo, occasionally.

Reactions at the injection site:

Lincomycin IM or IV is generally well tolerated. Occasionally, there have been irritation and pain at the injection site, induration, and abscesses with IM injection; cases have been reported thrombophlebitis by intravenous administration.

This list does not include all adverse reactions associated with the use of lincomycin, both well established as those that are under consideration or confirmation. In case you feel unwell, should immediately consult with the doctor who prescribed this medicine.

If you notice any side effects not listed in this website or in the leaflet accompanying the package, ask your doctor or pharmacist.

If any of the side effects gets serious, tell your doctor or pharmacist.

List of brands containing lincomycin     

This page contains a list of brands of authorized pharmaceutical specialties of the active principle lincomycin in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed their name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Warning:

With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.

Australia:     

LINCOCIN 600 mg/2 ml, injectable solution

Brazil:     

FARMICINA 600 mg/2 ml, injectable solution
FRADEMICINA 500 mg, 12 capsules
FRADEMICINA 300 mg/ml, injectable solution
LINCOFLAN 300 mg/ml injectable solution
LINCOMICINA NEO QUIMICA 300 mg/ml injectable solution
LINCOMICINA TEUTO 300 mg/ml injectable solution
LINCOMIRAL 300 mg/ml injectable solution
NEO LINCO 300 mg/ml injectable solution

Canada:     

LINCOCIN 300 mg/ml injectable solution
LINCOCIN 500 mg, 100 capsules

France:     

LINCOCINE 500 mg, 12 capsules
LINCOCINE 300 mg/ml injectable solution

Germany:     

N/A

India:     

ADMYCIN-L 300 mg/ml injectable solution
AMLINC 300 mg/ml injectable solution
LINCOCIN 500 mg, capsules
LINCOCIN 300 mg/ml injectable solution
LINCONIT 300 mg/ml injectable solution
LINCOSA 300 mg/ml injectable solution
LINCOZIN 250 mg, capsules
LINCOZIN 500 mg, capsules
LINCOZIN 125 mg/mL, syrup
LINCOZIN 300 mg/ml injectable solution
LINCY 300 mg/ml injectable solution
LINES 250 mg, capsules
LINES 500 mg, capsules
LINES 300 mg/ml injectable solution
LINK 500 mg, capsules
LINK 300 mg/ml injectable solution
LINKA 300 mg/ml injectable solution
LINTOP 250 mg, capsules
LINTOP 500 mg, capsules
LINTOP 300 mg/ml injectable solution
LIOD 250 mg, capsules
LIOD 500 mg, capsules
LIOD 300 mg/ml injectable solution
LIOD 125 mg/mL, syrup
LYCIN 300 mg/ml injectable solution
LYNX 250 mg, capsules
LYNX 500 mg, capsules
LYNX 125 mg/mL, syrup
LYNX 300 mg/ml injectable solution
PROLINC 300 mg/ml injectable solution

Italy:     

LINCOCIN 300 mg/ml injectable solution
LINCOCIN 500 mg, 12 capsules

Japan:     

LINCOCIN 250 mg, capsules

Mexico:     

BACTOKINA 300 mg/ml injectable solution
LIBIOCID 300 mg/ml injectable solution
LIMIDRAX 300 mg/ml injectable solution
LINCOCIN 500 mg, 12-16-24 capsules
LINCOCIN 250 mg/5 mL, 100 mL syrup
LINCOCIN 300 mg/ml injectable solution
LINCOMICINA AMSA 300 mg/ml injectable solution
LINCOVER 500 mg, 16 capsules
LINCOVER 300 mg/ml injectable solution
LISONIN 300 mg/ml injectable solution
LISONIN 500 mg, 12-16-18 capsules
LORIZ 300 mg/ml injectable solution
RIMSALIN 250 mg/5 ml, 100 mL syrup
RIMSALIN 500 mg, 12 capsules
RIMSALIN 300 mg/ml injectable solution
YECTOLIN 300 mg/ml injectable solution

Pakistan:     

AMLIN 300 mg/ml injectable solution
AMLIN 500 mg, capsules
BACTO-LINK 300 mg/ml injectable solution
DDS LINCOMYCIN 300 mg/ml injectable solution
ENCONMYCIN 300 mg/ml injectable solution
FLACIN 500 mg, capsules
IBUCIN 500 mg, capsules
L-SAF 500 mg, capsules
LIGON 300 mg/ml injectable solution
LIMERA 300 mg/ml injectable solution
LIMERA 500 mg, capsules
LINCIN 500 mg, capsules
LINCMY 500 mg, capsules
LINCO 300 mg/ml injectable solution
LINCO PLUS 300 mg/ml injectable solution
LINCO-T 300 mg/ml injectable solution
LINCOBECT 300 mg/ml injectable solution
LINCOBECT 500 mg, capsules
LINCOBIOTIC 300 mg/ml injectable solution
LINCOBIOTIC 500 mg, capsules
LINCOCEENA 300 mg/ml injectable solution
LINCOCEENA 500 mg, capsules
LINCOCIN 250 mg/5 ml syrup
LINCOCIN 300 mg/ml injectable solution
LINCOCIN 500 mg, capsules
LINCOCIN HFC 500 mg, capsules
LINCOGRAY 500 mg, capsules
LINCOL 250 mg/5 ml, syrup
LINCOLIDE 300 mg/ml injectable solution
LINCOLIVE 500 mg, capsules
LINCOM 300 mg/ml injectable solution
LINCOMATE 250 mg/5 ml, syrup
LINCOMATE 500 mg, capsules
LINCOMED 300 mg/ml injectable solution
LINCOMOX 300 mg/ml injectable solution
LINCOMYCIN ADAMJEE 250 mg/5 ml, syrup
LINCOMYCIN ADAMJEE 50 mg, capsules
LINCOMYCIN AMROS 300 mg/ml injectable solution
LINCOMYCIN AMROS 500 mg, capsules
LINCOMYCIN ELKO 300 mg/ml injectable solution
LINCOMYCIN HAJI 300 mg/ml injectable solution
LINCOMYCIN STAR 300 mg/ml injectable solution
LINCOMYCIN STAR 500 mg, capsules
LINCOMYCIN SWISS PHARMA 250 mg/5 ml, syrup
LINCOMYCIN SWISS PHARMA 500 mg, capsules
LINCOPHAR 500 mg, capsules
LINCOREX 300 mg/ml injectable solution
LINCOSOFT 500 mg, capsules
LINCOT 500 mg, capsules
LINCOTIC 250 mg/5 ml, syrup
LINCOTIC 300 mg/ml injectable solution
LINCOTIC 500 mg, capsules
LINCOTIN 300 mg/ml injectable solution
LINCOZAF 300 mg/ml injectable solution
LINKIT 300 mg/ml injectable solution
LINKIT 500 mg, capsules
LINKOWIN 250 mg/5 ml, syrup
LINKOWIN 300 mg/ml injectable solution
LINKRED 250 mg/5 ml, syrup
LINZEE 300 mg/ml injectable solution
LIOMYN 500 mg, capsules
LOCOMIN 500 mg, capsules
LOLIN 300 mg/ml injectable solution
LOMIVAC 500 mg, capsules
MB-LINCO 250 mg/5 ml, syrup
MB-LINCO 300 mg/ml injectable solution
MB-LINCO 500 mg, capsules
MEDILINC 500 mg, capsules
MINCOMYCIN 250 mg/5 ml, syrup
MINCOMYCIN 300 mg/ml injectable solution
MINCOMYCIN 500 mg, capsules
MYLINCO 500 mg, capsules
MYLINE 300 mg/ml injectable solution
MYLINO 500 mg, capsules
NOVELINK 500 mg, capsules
OLINC 150 mg/ml, injectable solution
OLINC 300 mg/ml injectable solution
OLINC 500 mg, capsules
OMICIN 250 mg/5 ml, syrup
OMICIN 300 mg/ml injectable solution
OMICIN 500 mg, capsules
OSLIN 300 mg/ml injectable solution
P-STAPH 300 mg/ml injectable solution
PLIMYCINE 300 mg/ml injectable solution
QINROX 150-300 mg, tablets
ROLINCO 500 mg, capsules
VIOCIN 300 mg/ml injectable solution
XINCOMIN 300 mg/ml injectable solution

Spain:     

LINCOCIN 500 mg, 24 capsules
LINCOCIN 300 mg/ml injectable solution
LINCOMICINA NORMON 300 mg/ml injectable solution

Turkey:     

LINCOCIN 300 mg/ml injectable solution
LINKOLES 300 mg/ml injectable solution
LINKOMED 300 mg/ml injectable solution
LINKOMISIN 300 mg/ml injectable solution
LINKOSOL 300 mg/ml injectable solution
LINOSIN 300 mg/ml injectable solution

United Kingdom:     

N/A

U.S.A. and Puerto Rico:     

LINCOCIN 300 mg/ml injectable solution

Page updated: December 21, 2010.